Respiratory viral co-infections: a systematic review on SARS CoV-2, Influenza Virus, Respiratory Syncytial Virus
DOI:
https://doi.org/10.56294/saludcyt2024634Keywords:
Respiratory Co-Infection, Virus, COVID 19, SARS Cov 2, Influenza Virus, Respiratory Syncytial Virus, Mixed Respiratory InfectionsAbstract
Introduction: respiratory diseases are an important cause of morbidity and mortality in the general population, but it affects older adults, children and immunocompromised people to a greater extent, with viruses being responsible for 80 % of these infections. Studies have shown that influenza virus and respiratory syncytial virus are the most commonly identified agents. Since 2019 with the beginning of the COVID-19 Pandemic, the world's population has undergone great changes, with thousands of infections, deaths and economic losses.
Methods: a systematic electronic search of articles published from 2018 to July 2023 was carried out in the databases PubMed, Springer Scielo, ELSEVIER, Google Scholar. Descriptive, retrospective, prospective, observational, meta-analysis, original articles were chosen, which provided statistical information, for their search keywords such as: COVID 1, co-infection, respiratory co-infection, SARS Cov-2 infection, influenza virus, respiratory syncytial virus.
Results: with the literature review, 552 articles were obtained, of which only 73 were chosen according to the eligibility criteria, excluding 52, with a total result of 21 scientific articles.
Conclusions: although the incidence of COVID-19 remains high, the prevalence of respiratory viral co-infections is relatively low. Global infection control measures may have contributed to reducing the circulation of respiratory viruses. All these actions should be directed for the benefit of the vulnerable population and should be cost-effective for health systems
References
1. Alonso D, Balsa J, Barbero JM, Hernández G. Neumonía vírica. Neumonía en la COVID-19. Rev Prolegómenos- Derechos y Valores [Internet]. 2017;20(39):87–104. Available from: https://ciencia.lasalle.edu.co/gs/vol3/iss2/13
2. Torrico NG, Copana RR, Torrico MV, Calderón ME, Parrado R. Epidemiologia molecular del SARS CoV-2, VSR y FLU en niños hospitalizados con infección respiratoria aguda grave. MGB. 2022;45(2):153–9.
3. Hernández G, Herrera A, Ramírez V. Etiología viral de las infecciones agudas del tracto respiratorio inferior en Cuba. Rev Arch Médico Camagüey [Internet]. 2018;22(5):651–76. Available from: http://www.redalyc.org/articulo.oa?id=211161292004
4. Florencia M, Del Valle M, Natalia M, Romero L, Orqueda AS, Mistchenko AS, et al. Impacto del COVID-19 en la circulación de virus respiratorios en un hospital pediátrico: una ausencia esperada. Arch Argent Pediatr. 2022;120(2):99–105.
5. Eşki A, Öztürk GK, Çiçek C, Gülen F, Demir E. Is viral coinfection a risk factor for severe lower respiratory tract infection? A retrospective observational study. Pediatr Pulmonol. 2021;56(7):2195–203.
6. Antalis E, Oikonomopoulou Z, Kottaridi C, Kossyvakis A, Spathis A, Magkana M, et al. Mixed viral infections of the respiratory tract; an epidemiological study during consecutive winter seasons. J Med Virol. 2018;90(4):663–70.
7. Pacheco GA, Gálvez NMS, Soto JA, Andrade CA, Kalergis AM. Bacterial and viral coinfections with the human respiratory syncytial virus. Microorganisms. 2021;9(6).
8. Vera K, Villafuerte J, Merchán K. Vigilancia De Virus Respiratorios En Ecuador. Rev Cient ciencias la salud. 2021;3:563–78.
9. Panamerican Health Organization. Alerta epidemiológica Influenza , virus respiratorio sincitial y SARS-CoV-2. 2023;
10. INEC. Registro Estadístico de Camas y Egresos Hospitalarios. Boletín Técnico. 2023;
11. Organización Internacional del Trabajo. Sistema Nacional Sanitario ecuatoriano y el COVID-19. Scielo [Internet]. 2021;2:1–7. Available from: https://www.ilo.org/wcmsp5/groups/public/---americas/---ro-lima/---sro-lima/documents/publication/wcms_799790.pdf
12. Mantovani A, Rinaldi E, Zusi C, Beatrice G, Saccomani MD, Dalbeni A. Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis. Pediatr Res [Internet]. 2021;89(4):733–7. Available from: http://dx.doi.org/10.1038/s41390-020-1015-2
13. Swets MC, Russell CD, Harrison EM, Dochert AB, Lone N, Girvan M, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. elservier [Internet]. 2020;(January):2020–2. Available from: https://doi.org/10.1016/S0140-6736(22)00280-X
14. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan. J Microbiol. 2020;54(January):19–21.
15. Ozaras R, Cirpin R, Duran A, Duman H, Arslan O, Bakcan Y, et al. Influenza and COVID-19 coinfection: Report of six cases and review of the literature. J Med Virol. 2020;92(11):2657–65.
16. Lansbury L, Lim B, Baskaran V, Lim WS. Co-Infections in People with COVID-19: A Systematic Review and Meta-Analysis. SSRN Electron J. 2020;(January).
17. Kumar N, Sharma S, Barua S, Tripathi BN, Rouse T. Virological and Immunological Outcomes of Coinfections. Clin Microbiol Rev [Internet]. 2018;22. Available from: https://doi.org/10 .1128/CMR.00111-17
18. En Wee L, Karrie Ko KK, Qi Ho W, Cheng Kwek GT, Tong Tan T, Wijaya L. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes. J Clin Virol [Internet]. 2020;128(May):104436. Available from: https://doi.org/10.1016/j.jcv.2020.104436
19. Adams K, Tastad KJ, Huang S, Ujamaa D, Kniss K, Cummings C, et al. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season. MMWR Morb Mortal Wkly Rep. 2022;71(50):1589–96.
20. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020;92(9):1549–55.
21. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–8.
22. Hazra A, Collison M, Pisano J, Kumar M, Oehler C, Ridgway JP. Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect Control Hosp Epidemiol. 2020;41(10):1228–9.
23. Jeong S, Lee N, Park Y, Kim J, Jeon K, Park MJ, et al. Prevalence and Clinical Impact of Coinfection in Patients with Coronavirus Disease 2019 in Korea. Viruses. 2022;14(2):1–13.
24. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect [Internet]. 2020;81(2):266–75. Available from: https://doi.org/10.1016/j.jinf.2020.05.046
25. Lehman C, Lehmann CJ, Pho MT, Pitrak D, Ridgway JP PN. Co-infection in COVID-19: A Retrospective Observational Experience. Xenobiotica [Internet]. 2020;0(0):000. Available from: http://dx.doi.org/10.1080/00498254.2020.1737890
26. Lv Z, Cheng S, Le J, Huang J, Feng L. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study. Microbes Infect. 2020;22(January):195–9.
27. Ma L, Wang W, Grange JM Le, Wang X, Du S, Li C, et al. Coinfection of SARS-CoV-2 and other respiratory pathogens. Infect Drug Resist. 2020;13:3045–53.
28. Ma S, Lai X, Chen Z, Tu S, Qin K. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect. 2020;96(January):683–7.
29. Malveste Ito CR, Moreira ALE, Silva PAN da, Santos M de O, Santos AP dos, Rézio GS, et al. Viral Coinfection of Children Hospitalized with Severe Acute Respiratory Infections during COVID-19 Pandemic. Biomedicines. 2023;11(5):1–15.
30. Scott SJ, Pfotenhauer B, Weiner JJ, Hilleshiem J, Khubbar M, Bhattacharyya S. Respiratory Pathogen Coinfections in SARS-CoV-2-Positive Patients in Southeastern Wisconsin: A Retrospective Analysis. Microbiol Spectr. 2021;9(2):1–9.
31. Si Y, Zhao Z, Chen R, Zhong H, Liu T, Wang M, et al. Epidemiological surveillance of common respiratory viruses in patients with suspected COVID-19 in Southwest China. BMC Infect Dis. 2020;20(1):1–7.
32. Sreenath K, Batra P, Vinayaraj E V., Bhatia R, SaiKiran K. Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea. Can J Infect Dis Med Microbiol. 2021;2021(1):1–13.
33. Steponavičienė A, Burokienė S, Ivaškevičienė I, Stacevičienė I, Vaičiūnienė D, Jankauskienė A. Influenza and Respiratory Syncytial Virus Infections in Pediatric Patients during the COVID-19 Pandemic: A Single-Center Experience. Children. 2023;10(1):126.
34. Wu Q, Xing Y, Shi L, Li W, Gao Y, Pan S, et al. Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics. 2020;146(1):1–9.
35. Zhang H, Zhang Y, Wu J, Li Y, Zhou X, Li X, et al. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect. 2020;9(1):1958–64.
36. Espino Solis GP, Leyva Aizpuru AP. Co-infecciones presentes durante la pandemia por COVID-19: Revisión Sistemática. TECNOCIENCIA Chihuahua. 2022;16(2):e974.
37. Krumbein H, Kümmel LS, Fragkou PC, Thölken C, Hünerbein BL, Reiter R, et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Rev Med Virol. 2023;33(1):1–10.
Published
Issue
Section
License
Copyright (c) 2024 Vanessa Pérez, Ricardo Recalde-Navarrete (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
